US Patent 12077595 Single domain antibodies that bind to CD137
Patent 12077595 was granted and assigned to Crescendo Biologics on September, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+25 properties)
Article (+151 characters)
US Patent 12077595 Single domain antibodies that bind to CD137
Article
Patent abstract
The disclosure relates to CD137 binding agents and the use of such binding agents in the treatment, prevention and detection of disease.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Brian McGuinness0
Carolyn Edwards0
Christine Rossant0
James Legg0
Jayesh Majithiya0
Verena Brucklacher-Waldert0
Yumin Teng0
Date of Patent
September 3, 2024
0Patent Application Number
167630590
Date Filed
November 13, 2018
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12077595 Single domain antibodies that bind to CD137
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.